Oorsprong van het eerstegraads netwerk van Marco Bottani
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
BioXell SpA
BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy.
7
| Extinct | Biotechnology | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Marco Bottani via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Hamilton Pharmaceuticals, Inc.
Hamilton Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Hamilton Pharmaceuticals, Inc. develops and supplies pharmaceuticals. It also develops and commercializes novel medical treatments for central nervous system disease. The company was founded in April 2004 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
Cellzome Ltd.
Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Genebiotech Co., Ltd.
Genebiotech Co., Ltd. BiotechnologyHealth Technology Part of Helixmith Co., Ltd., Genebiotech Co., Ltd. is a South Korean company that develops gene and cell-based machines. The company is based in Seoul, South Korea. Genebiotech Co. was acquired by Helixmith Co., Ltd. on May 30, 2006. | Biotechnology | Director/Board Member | |
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member | |
Sequenta, Inc.
Sequenta, Inc. BiotechnologyHealth Technology Sequenta, Inc. operates as a biotech company which discovers and develops clinical diagnostics based on immune system status. It develops molecular diagnostic assays based on a sequencing approach to the profiling of T and B cell receptor repertoires. The firm also provides sequencing-based test for minimal residual disease for leukemia and lymphoma. The company was founded by Thomas D. Willis and Malek Faham in 2007 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member | |
GENMAB A/S | Pharmaceuticals: Major | Director/Board Member | |
SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Director/Board Member | |
Earlybird Venture Capital GmbH & Co. KG
Earlybird Venture Capital GmbH & Co. KG Investment ManagersFinance Earlybird Venture Capital GmbH & Co. KG (Earlybird VC) is an independent venture capital firm founded by Hendrik Brandis, Roland Manger, Rolf Mathies, and Christian Nagel in 1997. It is a wholly-owned subsidiary of Earlybird VC Management GmbH & Co. KG. The firm is headquartered in Munich, Germany, with another German office in Berlin, and international office in Istanbul, Turkey. | Investment Managers | Private Equity Investor | |
ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Director/Board Member | |
Egalet Ltd.
Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Euronext Paris SA
Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France. | Investment Banks/Brokers | Director/Board Member | |
University of Pavia | College/University | Undergraduate Degree | |
University of Geneva | College/University | Director/Board Member | |
Max-Planck-Institute for Molecular Genetics | College/University | Doctorate Degree | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
7TM A/S
7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member | |
ProFibrix BV
ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member | |
Index Ventures (UK) LLP | Investment Managers | Private Equity Investor | |
Xenikos BV
Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Director/Board Member | |
Egalet A/S
Egalet A/S Pharmaceuticals: MajorHealth Technology Egalet A/S operates as a specialty pharmaceuticals company. It develops opioid formulations for pain management based on abuse deterrent prolonged release erosion matrix technology in Denmark. The company develops prolonged and delayed release therapeutics for chronic pain management, including Parvulet, a delivery platform for facilitating dispensing of oral doses to pediatric and geriatric patient segments; and Egalet morphine. The company was founded by Jan Quistgaard in 1995 and is headquartered in Vaerloese, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Vivonio Furniture GmbH
Vivonio Furniture GmbH Home FurnishingsConsumer Durables Vivonio Furniture GmbH operates as a holding company with interests in manufacturing furniture. The firm provides services through its subsidiaries Maja, Staud, Leuwico, Noteborn, and fm Büromöbel Franz Meyer GmbH & Co. KG. The company was founded in 2012 and is headquartered in Munich, Germany. | Home Furnishings | Chief Executive Officer | |
Levicept Ltd.
Levicept Ltd. Pharmaceuticals: GenericHealth Technology Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom. | Pharmaceuticals: Generic | Director/Board Member | |
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investment Managers | Founder | |
Vivonio Holding GmbH
Vivonio Holding GmbH Financial ConglomeratesFinance Vivonio Holding GmbH is a furniture holding German company that brings together seven successful European companies specializing in take-away and office furniture. The company is based in Munich, Germany, and has subsidiaries in Germany. Maja Kasendorf is one of the companies under the Vivonio Furniture GmbH umbrella, which produces contemporary take-away furniture with flexible production. The private company was founded in 2012, and the CEO is Elmar Duffner. | Financial Conglomerates | Director of Finance/CFO | |
ACER THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
UltraHuman Ltd.
UltraHuman Ltd. Miscellaneous Commercial ServicesCommercial Services UltraHuman Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Sandwich, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Critical Pressure Ltd.
Critical Pressure Ltd. Pharmaceuticals: MajorHealth Technology Critical Pressure Ltd. engages in research and experimental development on biotechnology. The firm develops products to treat vascular dysfunction and shock. The company is headquartered in Babraham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Kwistum Holding GmbH
Kwistum Holding GmbH Financial ConglomeratesFinance Kwistum Holding GmbH is an investment holding private company based in Munich, Germany. The CEOs of the German company are Elmar Duffner, Niels Ackermann. The company functions as an investment holding company. | Financial Conglomerates | Chief Executive Officer | |
MMB Verwaltungs GmbH
MMB Verwaltungs GmbH Miscellaneous Commercial ServicesCommercial Services Part of Vivonio Holding GmbH, MMB Verwaltungs GmbH is a German company that provides professional, scientific and technical services. The company is based in Munich, Germany. The CEOs of the company are Elmar Duffner, Niels Ackermann. | Miscellaneous Commercial Services | Chief Executive Officer | |
CENTOGENE N.V. | Miscellaneous Commercial Services | Director/Board Member | |
Inexia Ltd.
Inexia Ltd. Medical SpecialtiesHealth Technology Inexia Ltd. develops intranasal orexin positive modulators for the treatment of narcolepsy. The company is headquartered in London, the United Kingdom. | Medical Specialties | Director/Board Member | |
Rivus Pharmaceuticals, Inc.
Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rivus Pharmaceuticals, Inc. is a company dedicated to improving metabolic health by advancing a new class of medicines called controlled metabolic accelerators (CMAs). The company is based in Charlottesville, VA. Jayson Donald Alexander Dallas has been the CEO of the company since 2021. The company is a leader in mitochondrial biology and is developing a new class of medicines to address a primary driver of cardio-metabolic disease: obesity. Rivus' lead CMA is the investigational small molecule HU6 in development to treat obesity and associated metabolic diseases, including heart failure with preserved ejection fraction (HFpEF), metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH), and type 2 diabetes. | Pharmaceuticals: Major | Director/Board Member | |
Orexia Therapeutics Ltd.
Orexia Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Orexia Ltd. develop orally administered orexin positive modulators for the treatment of neurological diseases. The company was founded on October 5, 2018 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Synox Therapeutics Ltd.
Synox Therapeutics Ltd. BiotechnologyHealth Technology Synox Therapeutics Ltd. a clinical stage biopharmaceutical company. The company is headquartered in Dublin, Ireland. | Biotechnology | Director/Board Member | |
CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chairman | |
SDS Therapeutics Ltd.
SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services SDS Therapeutics Ltd. is a British biotechnology company founded in 2020 that provides research and development services. The company is based in Cambridge, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Zeneca AGro Gmbh | Sales & Marketing | ||
Maja-Möbelwerk GmbH
Maja-Möbelwerk GmbH Home FurnishingsConsumer Durables Part of Vivonio Furniture GmbH, MAJA-Möbelwerk GmbH is a furniture company based in Wittichenau, Germany. The CEOs are Niels Ackermann, Uwe Gottschlich, Heinz Hien. MAJA-Möbelwerk GmbH offers high-quality furniture designs for media, office, and living spaces. The German company also has a selection of furniture for design enthusiasts who value premium materials. The company's SET+ office furniture line creates a pleasant work atmosphere with a combination of glass and wood. MAJA-Möbelwerk GmbH also provides media innovations that transform homes into technology paradises, using the latest technology to create appealing products that inspire enthusiasm. The company was founded in 1990. | Home Furnishings | Chief Executive Officer |
Statistieken
Internationaal
Verenigd Koninkrijk | 13 |
Duitsland | 12 |
Verenigde Staten | 11 |
Zwitserland | 7 |
Denemarken | 4 |
Sectoraal
Health Technology | 28 |
Commercial Services | 9 |
Finance | 8 |
Consumer Services | 5 |
Consumer Durables | 3 |
Operationeel
Director/Board Member | 62 |
Independent Dir/Board Member | 15 |
Chairman | 15 |
Corporate Officer/Principal | 13 |
Chief Executive Officer | 8 |
Sterkste connecties
- Beurs
- Insiders
- Marco Bottani
- Bedrijfsconnecties